A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1997
10/23/1997	WO1997038983A1 Irreversible inhibitors of tyrosine kinases
10/23/1997	WO1997038982A1 Novel carboxylic acid derivatives, their production and use
10/23/1997	WO1997038981A1 NOVEL α-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
10/23/1997	WO1997038980A1 New carboxylic acid derivatives, their production and use
10/23/1997	WO1997038966A2 Cytoprotective compounds
10/23/1997	WO1997038709A1 Use of growth hormone
10/23/1997	WO1997038705A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997	WO1997038694A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/23/1997	WO1997038685A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997	WO1997038665A2 Inhibitors of farnesyl-protein transferase
10/23/1997	WO1997038579A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no)
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	CA2254823A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no)
10/23/1997	CA2251972A1 Combination therapy for reducing the risks associated with cardiovascular disease
10/23/1997	CA2251381A1 New carboxylic acid derivatives, their production and use
10/23/1997	CA2251292A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997	CA2251071A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997	CA2250907A1 Use of growth hormone
10/23/1997	CA2250764A1 Novel carboxylic acid derivatives, their production and use
10/23/1997	CA2250757A1 Novel .alpha.-hydroxylic acid derivatives, their production and use
10/23/1997	CA2249601A1 Inhibitors of farnesyl-protein transferase
10/23/1997	CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997	EP0802198A2 Pyridazino-, pyrimido, pyrazino and triazino-indoles
10/22/1997	EP0802197A1 Tricyclic-heterocyclyl substituted phenylacetamide derivatives, their preparation and their use as angiostensin-II-antagonists
10/22/1997	EP0802192A1 Heterocyclic-substituted phenylglycinolamides with antiatheroschlerotic activity and process for their production
10/22/1997	EP0802188A1 Phenylglycinolamides linked by a hetero-atom with antiatherosclerotic agents
10/22/1997	EP0802186A1 Benzyloxy-substituted phenylglycinolamides as pharmaceutical agents
10/22/1997	EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997	EP0801644A1 Polyarylcarbamoylaza -and- carbamoylalkanedioic acids
10/22/1997	EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997	EP0801572A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
10/22/1997	EP0801564A1 Use of nebivolol as an anti-atherogenic
10/22/1997	EP0681583B1 Tricyclic heterocyclic compounds as 5-ht4 receptor antagonists
10/22/1997	EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997	CN1162977A Modified Factor VII
10/22/1997	CN1162459A High performance and quick effective skin penetrating and slow releasing Chinese medical paste and preparations
10/21/1997	US5679782 Inhibit receptor binding activity of urokinase-type plasminogen activator
10/21/1997	US5679712 Antiarrhythmia agents, treatment of cardiovascular, nervous system disorders
10/21/1997	US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
10/21/1997	US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997	US5679677 Cardiovascular disorders
10/21/1997	US5679672 Anitarrhythmic agents
10/21/1997	US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
10/21/1997	US5679358 Formulations containing esculoside and the use thereof in the pharmaceutical and cosmetic fields
10/21/1997	US5679339 Method of using IL-11 for treating spondyloarthropies
10/21/1997	CA2015049C Pharmaceutically efficacious pteridine derivatives
10/21/1997	CA1339505C 2-substituted coumaran derivatives
10/18/1997	CA2202719A1 Hetero-linked phenylglycinolamides
10/18/1997	CA2202704A1 Benzyloxy-substituted phenylglycinolamides
10/18/1997	CA2202703A1 Novel pyridazino-, pyrimido-,pyrazino- and triazino-indoles
10/17/1997	CA2202579A1 Heterocyclically substituted phenylglycinolamides
10/17/1997	CA2202563A1 New arylacetamides
10/16/1997	WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997037983A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
10/16/1997	WO1997037979A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997	WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	WO1997037972A1 Novel vitamin d analogues
10/16/1997	WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997	WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997	WO1997037665A1 Method of treating heart failure with endothelin antagonists
10/16/1997	WO1997037655A1 αvβ3 ANTAGONISTS
10/16/1997	DE19614542A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997	DE19614534A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997	DE19614533A1 Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung New alpha-hydroxy-acid derivatives, their preparation and use
10/16/1997	CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997	CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0\|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997	CA2251308A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997	CA2251017A1 .alpha.v.beta.3 antagonists
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997	CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/15/1997	EP0801132A2 Staphylococcal FtsH protein
10/15/1997	EP0800827A1 Regulation of the reactivity of human blood platelets by administration of an extract of sea pine (pycnogenol TM)
10/15/1997	EP0800580A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
10/15/1997	EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/15/1997	EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
10/15/1997	EP0800516A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
10/15/1997	EP0800514A1 Substituted imides as tnf inhibitors
10/15/1997	EP0800504A1 Tricyclic retinoids, methods for their production and use
10/15/1997	EP0800391A1 Benzimidazoles as inhibitors of calcitriol metabolism
10/15/1997	EP0800389A1 Novel compounds
10/15/1997	EP0701556B1 N-((1-(4-fluorophenoxy)butyl)-4-piperidinyl)-n-methylamino-2-benzothiazolols as class iii antiarrhythmic agents
10/15/1997	EP0598770B1 New pyrazine derivatives, their preparation and their use
10/15/1997	EP0546102B1 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
10/15/1997	CN1162313A Substituted tetracyclic azepine derivatives having affinity for 5-HT2 receptors
10/15/1997	CN1162311A Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997	CN1162266A Novel brain endothelial cell protein and methods for its use
10/15/1997	CN1161960A Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing same
10/14/1997	US5677451 Controlling cell differentiation; skin disorders; anticancer agents
10/14/1997	US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase
10/14/1997	US5677324 Benzopyranes as potassium channel openers
10/14/1997	US5677321 Anesthetic premedication
10/14/1997	US5677319 Thiazole derivative
10/14/1997	US5677310 Hypertensive agents, migraine
10/14/1997	US5677306 Antagonizing alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, useful for treating all ischemias
10/14/1997	US5677297 Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/14/1997	US5677295 Immunosuppresive, antiinflammatory agnet, fungicides, antituor agents

1 ... 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 ... 1595